navenibart program

1 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Biocryst Pharmaceuticals, Inc.

BioCryst Names Pharma Veteran Menon as Chief R&D Officer Amid Pipeline Expansion

BioCryst appoints experienced pharma executive Sandeep Menon as Chief R&D Officer, bolstering leadership as it advances navenibart toward FDA approval.
BCRXFDA approvalclinical development